Company intelligence / Profile preview

QIX

Rochester, New York, USA

Ownership: Private
Development stage: Other

Overview

QIX (Quantitative Imaging Solutions) was a specialized contract research organization (CRO) providing advanced quantitative imaging services for clinical trials. The company focused on delivering high-quality imaging data and analysis to pharmaceutical and biotechnology companies to support drug development and regulatory submissions. QIX's expertise included the development and implementation of imaging biomarkers and standardized imaging protocols across various therapeutic areas. In 2014, the company was acquired by BioClinica (now part of Clario) to enhance its medical imaging capabilities and expand its service offerings in the clinical trial space.

Industry: Contract Research Organization

Partnerships

BioClinica

Beyond the preview

Go deeper on QIX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on QIX.

Explore the full profile